ACHN
Achillion Pharmaceuticals
ACHN
ACHN
Delisted
ACHN was delisted on the 27th of January, 2020.
124 hedge funds and large institutions have $307M invested in Achillion Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 45 increasing their positions, 34 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
26% less capital invested
Capital invested by funds: $415M → $307M (-$108M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
124
Holding in Top 10
1
Calls
$426K
Puts
$151K
Top Buyers
| 1 | +$5.11M | |
| 2 | +$2.54M | |
| 3 | +$2.4M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$720K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$689K |
Top Sellers
| 1 | -$5.38M | |
| 2 | -$4.08M | |
| 3 | -$4.06M | |
| 4 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$3.47M |
| 5 |
AG
Artal Group
Luxembourg
|
-$2.78M |